7 trends tracked about this subject — the full history, oldest to newest below.
A draft of the Treasury's COINS rule is expected to restrict the landscape for biotechnology dealmaking between the United States and China.
Zuckerberg's Biohub expands its virtual cell initiative to $1.8 billion with Meta, Google, and Isomorphic.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Novartis secures the rights to Abogen’s mRNA T cell engager in a massive $575 million upfront transaction.
Endpoints News has revealed the 2026 Endpoints 11, spotlighting the most exciting startups currently shaping the biotechnology landscape.
Takeda Pharmaceutical's R&D chief Andy Plump is set to retire in June 2027 following a period of significant pipeline reorganization and regulatory success.
Coverage reveals a third death in opaque Chinese clinical trials involving CAR-T therapy, intensifying global scrutiny.